These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 975418)

  • 1. Metabolism of piromidic acid, a new antibacterial agent. IV. Pharmacokinetics of piromidic acid in rats.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1462-70. PubMed ID: 975418
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of piromidic acid, a new antibacterial agent. II. In vitro metabolic pathway of piromidic acid in rats.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):437-42. PubMed ID: 1021250
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of piromidic acid, a new antibacterial agent. III. Determination of piromidic acid and its metabolites in blood, urine and bile of rats and humans.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1433-8. PubMed ID: 975416
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of piromidic acid, a new antibacterial agent. V. Pharmacokinetics of priomidic acid in humans.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2203-10. PubMed ID: 589722
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism in rats and man of piromidic acid, a new antibacterial agent.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Xenobiotica; 1976 Mar; 6(3):185-8. PubMed ID: 1274382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Researches on antibacterial and antifungal agents. II - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid.
    Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N
    Farmaco Sci; 1984 Feb; 39(2):95-109. PubMed ID: 6425079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tetroxoprim and sulphadiazine in various species.
    Vergin H; Fritschi E
    J Antimicrob Chemother; 1979 Nov; 5(B):103-18. PubMed ID: 536336
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of tetroxoprim and sulphadiazine in human volunteers.
    Reeves DS; Broughall JM; Bywater MJ; Holt HA; Vergin H
    J Antimicrob Chemother; 1979 Nov; 5(B):119-38. PubMed ID: 536337
    [No Abstract]   [Full Text] [Related]  

  • 9. Principles of clinical pharmacokinetics of antimicrobial drugs.
    Sams RA
    J Am Vet Med Assoc; 1984 Nov; 185(10):1068-71. PubMed ID: 6511566
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacokinetics and tissue penetration of ofloxacin.
    Lockley MR; Wise R; Dent J
    J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and tissue penetration of norfloxacin.
    Adhami ZN; Wise R; Weston D; Crump B
    J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic study of an antibacterial agent: clofoctol after intravenous administration in the rabbit (author's transl)].
    Koskas JP; Leverge R; Devissaguet JP
    J Pharm Belg; 1982; 37(1):72-7. PubMed ID: 7077515
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum protein binding and extravascular distribution of antimicrobials.
    Gerding DN; Peterson LR
    J Antimicrob Chemother; 1985 Feb; 15(2):136-8. PubMed ID: 3980308
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxolinic acid metabolism by man.
    Dicarlo FJ; Crw MC; Melgar MD; Roemer S; Ringel SM; Haynes LJ; Wilson M
    Arch Int Pharmacodyn Ther; 1968 Aug; 174(2):413-27. PubMed ID: 4882350
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics of ethonium administered perorally].
    Mogilevich SE; Galushko SV; Klebanov BM
    Farmakol Toksikol; 1987; 50(2):82-4. PubMed ID: 3582639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of food on the bioavailability of alafosfalin, a new antibacterial agent.
    Welling PG; Kendall MJ; Dean S; Wise R; Andrews JM
    J Antimicrob Chemother; 1980 May; 6(3):373-9. PubMed ID: 6893196
    [No Abstract]   [Full Text] [Related]  

  • 17. High-performance liquid chromatographic procedure for the determination of rat plasma concentrations of a new antibacterial agent, (+-)-9-fluoro-6,7- dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H- benzo[i,j]quinolizine-2-carboxylic acid, for topical use.
    Koike M; Akiyama H; Shimizu T
    J Chromatogr; 1990 Mar; 526(1):235-9. PubMed ID: 2341538
    [No Abstract]   [Full Text] [Related]  

  • 18. Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding.
    Squires RF; Saederup E
    Mol Pharmacol; 1993 May; 43(5):795-800. PubMed ID: 8388990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tissue cage model in the distribution of antibacterial agents.
    Chisholm GD
    Scand J Infect Dis Suppl; 1978; (14):118-24. PubMed ID: 279964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative chemotherapy].
    Spitzy KH
    Int J Clin Pharmacol; 1974 Oct; 10(3):230-8. PubMed ID: 4426723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.